Prognostic Value of Machine Learning in Patients with Acute Myocardial Infarction

Abstract

(1) Background: Patients with acute myocardial infarction (AMI) still experience many major adverse cardiovascular events (MACEs), including myocardial infarction, heart failure, kidney failure, coronary events, cerebrovascular events, and death. This retrospective study aims to assess the prognostic value of machine learning (ML) for the prediction of MACEs. (2) Methods: Five-hundred patients diagnosed with AMI and who had undergone successful percutaneous coronary intervention were included in the study. Logistic regression (LR) analysis was used to assess the relevance of MACEs and 24 selected clinical variables. Six ML models were developed with five-fold cross-validation in the training dataset and their ability to predict MACEs was compared to LR with the testing dataset. (3) Results: The MACE rate was calculated as 30.6% after a mean follow-up of 1.42 years. Killip classification (Killip IV vs. I class, odds ratio 4.386, 95% confidence interval 1.943–9.904), drug compliance (irregular vs. regular compliance, 3.06, 1.721–5.438), age (per year, 1.025, 1.006–1.044), and creatinine (1 µmol/L, 1.007, 1.002–1.012) and cholesterol levels (1 mmol/L, 0.708, 0.556–0.903) were independent predictors of MACEs. In the training dataset, the best performing model was the random forest (RDF) model with an area under the curve of (0.749, 0.644–0.853) and accuracy of (0.734, 0.647–0.820). In the testing dataset, the RDF showed the most significant survival difference (log-rank p = 0.017) in distinguishing patients with and without MACEs. (4) Conclusions: The RDF model has been identified as superior to other models for MACE prediction in this study. ML methods can be promising for improving optimal predictor selection and clinical outcomes in patients with AMI.

Research progress on detection techniques for point-of-care testing of foodborne pathogens

“…With the advancement of science and technology, artificial intelligence, gene editing, nanotechnology, and other cutting-edge disciplines, the integration of these technologies and POCT technology in the rapid detection of foodborne pathogens will also become the future development trend ( He et al, 2018 ; Chen et al, 2020c ; Ding et al, 2020 ; Peng et al, 2020b ; Yang et al, 2020c ; Gong et al, 2021 ; Xiao et al, 2022 ). The following is the prospect of POCT technology in the future development trend: 1) the detection index is gradually transformed from biochemical and immunity to nucleic acid molecules, and from single to multiple indicators.…”

A simple APACHE IV risk dynamic nomogram that incorporates early admitted lactate for the initial assessment of 28-day mortality in critically ill patients with acute myocardial infarction

“…In 2022, Xiao et al employed six machine learning methods to construct predictive models for the occurrence of major adverse cardiovascular events (MACEs) in AMI patients. The results showed that the best performer was the random forest model, with an AUC of (0.749, 0.644–0.853) [ 47 ]. However, these models did not explore the calibration of the models and the DCA curves, which are very important indicators of the model efficacy.…”

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases

“…It affects around 40 to 50 million people worldwide, but the number of cases is expected to triple by 2050 due to population growth and aging [ 5 ]. Although many efforts have been made in the past few decades, the complex pathogenesis of the disease remains unclarified, which limits the development of both diagnosis and treatment methods [ 100 , 101 , 102 , 103 ]. The potential of miRNA as biomarkers for early diagnosis of AD has attracted much attention as more and more miRNAs have been found altered in various processes implicated in AD.…”